695P Drug-drug interactions between pazopanib and proton pump inhibitors may significantly affect clinical outcome of patients affected by metastatic renal cell carcinoma
Autor: | Del Re, M., Brighi, N., Rizzo, M., Paolieri, F., Rebuzzi, S.E., Beninato, T., Crucitta, S., Mercinelli, C., Gri, N., Puglisi, S., Verzoni, E., Bleve, S., Cucchiara, F., Procopio, G., Fornarini, G., Galli, L., Porta, C.G., De Giorgi, U., Danesi, R. |
---|---|
Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S709-S709 |
Databáze: | ScienceDirect |
Externí odkaz: |